date/time interval
- January 25, 2024 - January 24, 2029
PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers
Grant
Overview
awarded by
administered by
sponsor award ID
- 75N91024D00006
Affiliation
contributor
- Boyer, Julie L. Co-Investigator 2024 - 2029
- Lipkin, Steven Principal Investigator 2024 - 2029
- Lipman, Neil Key Personnel 2024 - 2029